Market Tracker

12/09 5:16pm ET

Haemonetics Corp (NYSE:HAE)

40.04
Delayed Data
As of Dec 09
 +0.03 / +0.07%
Today’s Change
25.98
Today|||52-Week Range
40.75
+24.19%
Year-to-Date
Haemonetics Introduces Upgraded NextGen DMS 4 Software
Dec 09 / Zacks.com - Paid Partner Content
Haemonetics (HAE) Hits a 52-Week High on Solid Prospects
Nov 28 / Zacks.com - Paid Partner Content
MedTech Sails Through Macro Woes: Stocks in Focus
Dec 02 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close40.01
Today’s open40.09
Day’s range39.65 - 40.29
Volume383,630
Average volume (3 months)350,061
Market cap$2.1B
Dividend yield--
Data as of 4:02pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-440.62%
Earnings growth (this year)-8.04%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+0.02%
P/E ratioNM
Price/Sales1.97
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
PENPenumbra Inc-0.30-0.45%
PODDInsulet Corp+0.08+0.21%
HYHHalyard Health Inc+0.63+1.64%
GMEDGlobus Medical Inc+0.14+0.58%
Data as of 4:02pm ET, 12/09/2016

Financials

Next reporting dateFebruary 6, 2017
EPS forecast (this quarter)$0.40
Annual revenue (last year)$910.5M
Annual profit (last year)-$55.6M
Net profit margin-6.10%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Christopher Simon
Chief Financial Officer
William P. Burke
Corporate headquarters
Braintree, Massachusetts

Forecasts